INDSWFTLAB

Ind-Swift Laboratories Ltd.

330.20-6.5 (-1.95%)
19 Nov, 12:00 AM

Annual Reports and Financial Documents

Ind-Swift Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls—————————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Ind-Swift Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet4 Nov 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026.
  2. Monitoring Agency Report3 Nov 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report for the quarter ended September 30, 2026 in respect of receipt of funds raised through preferential issue of 70,00,000 Fully Convertible Warrants
  3. Monitoring Agency Report3 Nov 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report for the quarter ended September 30, 2026 in respect of funds raised through Preferential Issue 2.6 Cr Fully Convertible Warrants
  4. Analyst / Investor Meet30 Oct 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find enclosed Schedule of Analyst / Investor Meet which will be held on Wednesday, November 04, 2026, at 04.00 P.M. IST in respect of financial results of the Company for the quarter ....
  5. Press Release / Media Release30 Oct 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release in respect of Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026
  6. Reg. 32 (1), (3) - Statement of Deviation & Variation29 Oct 2026
    NIL STATEMENT ON DEVIATION OR VARIATION OF FUNDS RAISED THROUGH PREFERENTIAL ISSUE OF 70,00,000 FULLY CONVERTIBLE WARRANTS
    Please refer attached pdf
  7. Reg. 32 (1), (3) - Statement of Deviation & Variation29 Oct 2026
    NIL STATEMENT ON DEVIATION OR VARIATION OF FUNDS RAISED THROUGH PREFERENTIAL ISSUE OF 2,60,00,000 FULLY CONVERTIBLE WARRANTS
    Please refer attached pdf
  8. Outcome of Board Meeting29 Oct 2026
    Board Meeting Outcome for Outcome Of Board Meeting Dated October 29, 2026
    Please find enclosed outcome of the Board Meeting held on October 29, 2026
  9. Board Meeting15 Oct 2026
    Board Meeting Intimation for Meeting To Be Held On October 29, 2026.
    Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve inter alia, to Consider ....
  10. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201112 Oct 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Essix Biosciences Ltd & Others
  11. General12 Oct 2026
    Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
    Please refer attached pdf.
  12. Conversion of Securities8 Oct 2026
    Announcement under Regulation 30 (LODR)-Conversion of Securities
    Please find outcome of Preferential Issue Committee Meeting held on Oct. 08, 2026
  13. Newspaper Publication6 Oct 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed newspaper clippings informing stakeholders regarding special window for relodgement of physical shares
  14. AGM5 Oct 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find enclosed scrutiniser''s report along with voting results for the 31st AGM, held on 30th September, 2026
  15. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20185 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please refer the attached pdf
  16. AGM30 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Please find enclosed proceedings of the 31st Annual General Meeting of the company held on Wednesday, 30th Sept., 2026.
  17. General28 Sept 2026
    Intimation To The Shareholders Of Physical Securities Pursuant To SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07, 2024
    Please refer attached pdf
  18. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Please refer the attached pdf.
  19. Analyst / Investor Meet23 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find enclosed Schedule of Analyst / Investor Meet scheduled to be held on Tuesday, 29th September, 2026, at 01.00 P.M. IST
  20. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201122 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Essix Biosciences Ltd & Others

Frequently Asked Questions

Where can I download the annual report of Ind-Swift Laboratories Ltd.?
Annual reports of Ind-Swift Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Ind-Swift Laboratories Ltd.?
Quarterly earnings results and presentations of Ind-Swift Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Ind-Swift Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Ind-Swift Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Ind-Swift Laboratories Ltd.?
Investor presentations and annual day presentations of Ind-Swift Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Ind-Swift Laboratories Ltd.?
Corporate announcements and regulatory filings of Ind-Swift Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Ind-Swift Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Ind-Swift Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Ind-Swift Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Ind-Swift Laboratories Ltd. is INE915B01019. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Ind-Swift Laboratories Ltd. listed?
Ind-Swift Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is INDSWFTLAB and the BSE code is -.
Where can I find the shareholding pattern of Ind-Swift Laboratories Ltd.?
The quarterly shareholding pattern of Ind-Swift Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Ind-Swift Laboratories Ltd. on Sharpely?
Share price data for Ind-Swift Laboratories Ltd. is updated as of 19 Nov 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.